Company news
Codexis, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Codexis and Casdin Capital Launch SynBio Innovation Accelerator
November 23, 2020
Codexis to Participate at Three Virtual Investment Conferences in November
November 8, 2020
Codexis Reports Third Quarter 2020 Financial Results
November 4, 2020
Codexis to Hold Third Quarter 2020 Conference Call on November 5
October 28, 2020
Codexis to Present at Two Virtual Investment Conferences in September
September 7, 2020
Codexis Reports Second Quarter 2020 Financial Results
August 5, 2020
Codexis Adds Dr. Jennifer L. Aaker to its Board of Directors
August 5, 2020
Codexis to Hold Second Quarter 2020 Conference Call on August 6
July 29, 2020
Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis
June 22, 2020
Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders
June 15, 2020
Codexis and Alphazyme Partner to Offer Novel Enzymes to Life Science and Diagnostic Markets
May 31, 2020
Codexis to Participate in Two Virtual Investment Conferences
May 26, 2020
Codexis to Present at the UBS Virtual Healthcare Conference
May 10, 2020
Codexis Reports First Quarter 2020 Financial Results
May 6, 2020
Codexis Achieves Technology Transfer Milestone with Global Pharmaceutical Leader
May 5, 2020
Codexis Expands and Strengthens its Leadership Team with Two Executive Hires
May 4, 2020
Codexis to Hold First Quarter 2020 Conference Call on May 7
April 29, 2020
Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders
March 22, 2020
Codexis Reports 2019 Fourth Quarter and Full Year Financial Results
February 26, 2020
Codexis to Present at Two Investment Conferences in March
February 24, 2020
Codexis to Hold 2019 Fourth Quarter and Full Year Conference Call on February 27
February 19, 2020
Codexis Attends Opening Ceremony for Porton’s Fermentation Pilot Lab in Chongqing
January 12, 2020
Codexis and Nestlé Health Science Sign Development Agreement to Advance Therapeutic Candidate towards Clinical Studies and Extend Strategic Collaboration Agreement
January 9, 2020
Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing
December 22, 2019
Codexis Announces the Publication with Merck of an Efficient Enzymatic Cascade Process for Synthesis of Investigational Anti-HIV Agent, Islatravir
December 4, 2019
Codexis to Participate in Four Investment Conferences in November
November 4, 2019
Codexis Reports Third Quarter 2019 Financial Results
November 4, 2019
Codexis to Hold Third Quarter 2019 Conference Call on November 5
October 28, 2019
Codexis’ Protein Engineering Forum Highlights Progress and Future Direction of the Field
October 14, 2019
Codexis to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
September 25, 2019
Codexis Spreading the Promise of Engineered Proteins at SynBioBeta Summit
September 25, 2019
Calls
The 5 newest of 18 calls. Every call is listed under its year.
- Codexis (NASDAQ:CDXS) Q2 2026 Earnings Call
Aug 11, 2026
Transcript - Codexis (NASDAQ:CDXS) Q1 2026 Earnings Call
May 7, 2026
Transcript - Codexis (NASDAQ:CDXS) Q4 2025 Earnings Call
Mar 11, 2026
Transcript - Codexis (NASDAQ:CDXS) Q3 2025 Earnings Call
Nov 6, 2025
Transcript - Codexis (NASDAQ:CDXS) Q2 2025 Earnings Call
Aug 13, 2025
Transcript
Decks
The 5 newest of 24 decks. Every deck is listed under its year.
- Investor Presentation (September 2026)
Investor deck · 29 slides · September 2026
- Q2 2026 Earnings Presentation
Earnings · 29 slides · Aug 11, 2026
- Q1 2025 Earnings Presentation
Earnings · 10 slides · May 14, 2025
- Q4 2024 Earnings Presentation
Earnings · 12 slides · Feb 27, 2025
- Q3 2024 Earnings Presentation
Earnings · 13 slides · Oct 31, 2024